1. Home
  2. HDL vs FLGT Comparison

HDL vs FLGT Comparison

Compare HDL & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HDL

SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

HOLD

Current Price

$10.69

Market Cap

582.5M

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

N/A

Current Price

$24.80

Market Cap

511.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HDL
FLGT
Founded
2016
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
582.5M
511.0M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
HDL
FLGT
Price
$10.69
$24.80
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $17.60
N/A
AVG Volume (30 Days)
1.8K
★ 327.1K
Earning Date
11-25-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $18,730,000.00
Revenue This Year
$9.19
$3.85
Revenue Next Year
$14.22
$9.64
P/E Ratio
$55.56
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.74
$13.46
52 Week High
$18.33
$31.04

Technical Indicators

Market Signals
Indicator
HDL
FLGT
Relative Strength Index (RSI) 44.13 63.12
Support Level $10.68 $18.82
Resistance Level $14.04 N/A
Average True Range (ATR) 0.22 1.43
MACD -0.01 0.55
Stochastic Oscillator 43.89 71.13

Price Performance

Historical Comparison
HDL
FLGT

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company, and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Share on Social Networks: